Anne Labonté - Concepedia

Author

Anne Labonté

McGill University ORCID

Also Known As

A Labonte, A. Labonté, Adèle Labonté, Anne Labonte, Anne Labonté, Anne Labonté, Gabriel Jean, Labonté, Anne

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

McGill University Douglas Mental Health University Institute Montreal Neurological Institute and Hospital University of Gothenburg University College London

About

Anne Labonté is an author at McGill University specializing in medicine, social sciences, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	281
2	Social Sciences	5	5	222
3	Health Sciences	1	1	13
4	Cognitive Science	1	1	71
5	Geriatrics	1	1	13

Anne Labonté

Publications

962

Citations

H-Index

Page 1

	Year	Citations
Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment Cherie Strikwerda‐Brown, Diana A. Hobbs, Julie Gonneaud, JAMA Neurology	2022	124
Plasma p‐tau231, p‐tau181, <scp>PET</scp> Biomarkers, and Cognitive Change in Older Adults Pierre‐François Meyer, Nicholas J. Ashton, Thomas K. Karikari, Annals of Neurology	2022	95
Subjective Cognitive Decline Is Associated With Altered Default Mode Network Connectivity in Individuals With a Family History of Alzheimer’s Disease Sander C.J. Verfaillie, Alexa Pichet Binette, Étienne Vachon‐Presseau, Biological Psychiatry Cognitive Neuroscience and Neuroimaging Cognitive ScienceAlzheimer's DiseaseNeurological FunctioningBrain FunctionMedicine	2017	71
Amyloid and Tau Pathology Associations With Personality Traits, Neuropsychiatric Symptoms, and Cognitive Lifestyle in the Preclinical Phases of Sporadic and Autosomal Dominant Alzheimer’s Disease Alexa Pichet Binette, Étienne Vachon‐Presseau, John C. Morris, Biological Psychiatry Neurodegenerative DiseasesNeuropsychologyAlzheimer's DiseaseTau Pathology AssociationsNeurology	2020	70
Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease Cynthia Picard, Nathalie Nilsson, Anne Labonté, Alzheimer s & Dementia	2021	64
Proprotein convertase subtilisin/kexin type 9 (PCSK9) in Alzheimer’s disease: A genetic and proteomic multi-cohort study Cynthia Picard, Alexandre Poirier, Stéphanie A.H. Bélanger, PLoS ONE	2019	53
New concepts in benzodiazepine therapy: Rebound anxiety and new indications for the more potent benzodiazepines Guy Chouinard, Anne Labonté, Réjean Fontaine, Progress in Neuro-Psychopharmacology and Biological Psychiatry Benzodiazepine TherapyPsychoactive DrugPsychiatryPsychotropic MedicationRebound Anxiety	1983	46
Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer’s Disease Pathogenesis Pierre‐François Meyer, Mélissa Savard, Judes Poirier, Journal of Alzheimer s Disease Immune RegulationImmunologyNeurochemical BiomarkersImmune SystemAlzheimer ’	2018	46
Development of Homogeneous Nonradioactive Methyltransferase and Demethylase Assays Targeting Histone H3 Lysine 4 Nancy Gauthier, Mireille Caron, Liliana Pedro, SLAS DISCOVERY	2011	41
Intermediate flortaucipir uptake is associated with Aβ-PET and CSF tau in asymptomatic adults Melissa McSweeney, Alexa Pichet Binette, Pierre‐François Meyer, Neurology	2020	40

Page 1